SCHEMBL23937852

SCHEMBL23937852

CNC(=O)c1cc(O)c2ccn(C)c2n1

nearest known ligand 0.40

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BAZ2B Q9UIF8 1/20 0.40
CHRM1 P11229 5/20 0.39
HSD17B10 Q99714 1/20 0.36
BRD4 O60885 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20674243 0.82 LCK (0.41)
SCHEMBL20674244 0.79 CHRM1 (0.31) CHRM1BRD4
SCHEMBL20674062 0.77 PDE2A (0.43) BAZ2BBRD4
SCHEMBL23937850 0.77 BAZ2B (0.40) BAZ2BHSD17B10BRD4
SCHEMBL23937851 0.75 TLR7 (0.35) BAZ2BCHRM1HSD17B10BRD4
SCHEMBL23937755 0.72 FTO (0.36) BRD4
SCHEMBL20674247 0.70 HRH4 (0.34)
SCHEMBL23937675 0.70 TUBB4A (0.39) BRD4
SCHEMBL22204309 0.67 RXFP1 (0.40)
SCHEMBL19932639 0.67 KMT2A (0.43) HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3399968-B1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS PHARMATECH LTD (KY) 2021-10-20 EP disclosed